Cannabis-Induced Psychosis: What Is It and Who Is at Risk?

Cannabis can trigger psychotic symptoms, including hallucinations, delusions and severe disorganization. New symptoms need prompt professional assessment, even if they begin after using cannabis. Do not assume they will disappear once the high wears off or that they are harmless because a person has no known psychiatric history.

Recognizing Psychosis and Getting Help

Psychosis involves difficulty distinguishing reality from experiences or beliefs that other people do not share. Warning signs can include hearing voices, being convinced someone is pursuing you despite contrary evidence, markedly confused speech or behavior that makes ordinary activities unsafe.

As NIMH explains, psychosis can have multiple causes, including mental illnesses, medical conditions, sleep deprivation, medications and substances. A clinician needs to assess those possibilities. Anxiety during intoxication and a diagnosable psychotic disorder are not interchangeable.

If there is immediate danger, severe agitation, inability to stay safe or another medical emergency, call emergency services. In the United States, call 911 for life-threatening situations; call or text 988 for a mental-health crisis. Early treatment can improve recovery.

While arranging help, avoid further cannabis or other intoxicants. Do not drive. If assisting someone, speak calmly and focus on their distress rather than arguing about a belief or endorsing it as true. Prioritize everyone’s safety and follow emergency responders’ instructions.

What Cannabis-Induced Psychosis Means

The diagnosis describes clinically significant psychotic symptoms associated with cannabis exposure after other explanations have been considered. Establishing the timing of cannabis use helps, but timing alone cannot prove the cause. Symptoms may persist beyond ordinary intoxication, and an initial diagnosis may change during follow-up.

Some people recover from an episode without another one. Others have recurrent symptoms or later receive a diagnosis such as schizophrenia or bipolar disorder. There is no reliable home test or fixed number of days that distinguishes those outcomes.

The relationship is more complex than cannabis simply revealing a pre-existing genetic condition. Individual vulnerability and exposure can both matter. Most people who use cannabis do not develop a persistent psychotic disorder, but that does not make the risk negligible for a person experiencing symptoms.

Risk Factors and Product Exposure

Higher THC exposure and frequent use are important concerns. High-potency products can deliver substantial amounts, while delayed effects from edibles can lead to taking more before the first dose is fully felt. Product category alone is insufficient: an edible can contain a low or high dose.

A 2022 international survey found higher rates of cannabis-associated psychotic symptoms requiring emergency treatment among younger respondents, people reporting certain mental-health diagnoses and users of high-potency resin. The associations do not prove that every listed factor independently causes an episode.

The same survey estimated that 0.47% reported such an event during their lifetime. That was a self-reported emergency-treatment outcome in a volunteer survey, not the prevalence of all psychotic symptoms, a diagnosis rate for all cannabis users or an individual’s personal risk.

A personal or family history of psychosis is a strong reason to avoid cannabis and discuss the issue with a clinician. Bipolar illness, other psychiatric symptoms, other substance use and severe sleep disruption also warrant individual assessment. A lower-THC product cannot guarantee protection.

Why Follow-Up Matters After an Episode

A 2026 Swedish register study compared people with cannabis-induced psychosis, first-episode psychosis with cannabis use disorder, and first-episode psychosis without a substance-use disorder. The cannabis-induced group included 1,772 individuals.

Both cannabis-related groups had higher adjusted risks of subsequent hospitalization for psychosis and death than the comparison group. The observational design cannot prove that cannabis alone caused those differences, and the findings concern diagnosed patients rather than everyone who has used cannabis.

Nonetheless, the results directly challenge the idea that an episode labeled cannabis-induced can be dismissed as a short-lived inconvenience. Follow-up remains important after acute symptoms improve, including reassessment of mood, sleep, functioning, substance use and treatment needs.

Assessment and Treatment

Tell the treating team what was used, when, the estimated amount, and whether other drugs or medicines were involved. Bring product packaging if available. Information about changes before the episode, such as poor sleep or declining functioning, can also help.

Treatment depends on severity and diagnosis and may include antipsychotic medication, psychological support and assistance stopping cannabis. NIMH describes coordinated specialty care as a team approach that can combine medication management, therapy, family support and help with work or education.

Care should address cannabis use and psychiatric symptoms together. Waiting until symptoms have lasted an arbitrary number of days before seeking treatment is inappropriate. Likewise, a person should not stop a prescribed psychiatric medicine or try to manage an episode with CBD, alcohol or another cannabis product.

Reducing the Chance of Another Episode

After a suspected cannabis-associated psychotic episode, avoiding cannabis and discussing a continuing care plan are more appropriate than experimenting with a different strain. Follow-up appointments provide an opportunity to review symptoms, side effects and practical support.

People considering cannabis for a medical condition should disclose psychiatric and family history before treatment. Potential benefits for one symptom do not remove the possibility of serious adverse effects. Recognizing warning signs and obtaining help early are the most useful actions if psychosis occurs.